TITLE

Nephrology/pediatric nephrology

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS63
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Renal ischemia stimulates expression of tubular AT2, angiotensin II receptor mRNA,' by K.D. Burns and J. Kontogiannis.
ACCESSION #
9708236715

 

Related Articles

  • Myocardial angiotensin II receptor expression and ischemia-reperfusion injury. Yang, B.; Li, D.; Mehta, J.L.; Mehta, P.; Phillips, M.I. // Vascular Medicine;1998, Vol. 3 Issue 2, p121 

    The renin–angiotensin system plays an important role in myocardial ischemia-reper-fusion injury. Angiotensin II (Ang II) contributes to the evolution of ischemic coronary events through its hemodynamic, hemostatic and mitogenic effects. Angiotensin-converting enzyme (ACE) inhibitors and...

  • THE EFFECTS OF VALSARTAN ON ANGIOTENSIN II TYPE 1 AND TYPE 2 RECEPTOR IN ISOLATED REPERFUSED ISCHAEMIC RAT HEARTS.  // Heart;Oct2010 Supplement, pA108 

    An abstract of the article "The Effects of Valsartan of Angiotensin II Type I and Type 2 Receptor in Isolated Reperfused Ischaemic Rat Hearts," by Zhang Yingjie and colleagues is presented.

  • A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. du Toit, Eugene F.; Nabben, Marinda; Lochner, Amanda // Basic Research in Cardiology;Jul2005, Vol. 100 Issue 4, p346 

    Background The mechanisms for obesity induced myocardial remodelling and subsequent mechanical dysfunction are poorly understood. There is good evidence that angiotensin II and TNFα have strong growth promoting properties and are elevated with obesity. In addition, these two peptides may...

  • Efficacy of Pretreatment With the Angiotensin II Type 1 Receptor Blocker UP269-6 and Losartan in the Dog: Effect on Hemodynamics and Ischemia-Reperfusion. O'Brien, Darryl W.; Yi Xu; Menon, Vijayan; Jugdutt, Bodh I. // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2000, Vol. 5 Issue 2, p129 

    The article discusses a study which examined the efficacy of pretreatment using the novel oral angiotensin II type I receptor (AT[sub1]R) antagonist UP269-6 (UP) and losartan (LN) in dogs. It discusses the effects of the pretreatment on hemodynamics and ischemia-reperfusion (IR) in dogs. The...

  • Losartan protects the rat kidney from ischemic injury. Heller, Jiří; Kramer, Herbert J.; Cervenka, Ludĕk; Hellerová, Soň // Kidney International;Jun1996 Supplement, Vol. 49, p113 

    Administration of losartan (L), an angiotensin II receptor antagonist, at a daily dose of 3 mg/kg body wt, lowered systolic blood pressure (SBP) in both the Prague hypertensive rat and the Prague normotensive rat (PNR). Proteinuria was markedly reduced in both strains by L. Seven days after...

  • DD Genotype of the angiotensin - converting enzyme gene and stroke in Slovenian population. Peterlin, Borut; Milanez, Toma&zvreve;; Kobal, Jan; Peterlin-Potisk, Karmen; Petrovič, Daniel; Grad, Anton; Pogačnik, Toma&zbreve; // Pflugers Archiv European Journal of Physiology;Apr2000, Vol. 439 Issue 7, pr038 

    The angiotensin-converting enzyme (ACE) is a rate-limiting enzyme in the renin angiotensin system, the enzyme is involved in the vascular remodelling and atherosclerosis. Its significance in pathogenesis of ischemic cerebrovascular insults (CVI) is not known. We analysed 124 Slovenian patients...

  • Enalapril: Fewer ischemic events in patients with cardiac damage.  // Geriatrics;Mar1993, Vol. 48 Issue 3, p91 

    The article reports on the role of the drug enalapril in reducing ischemic events in patients with cardiac damage. Treatment with enalapril in addition to conventional therapy with digitalis, diuretics and vasodilators other than angiotensin-converting enzyme inhibitors reduces the risk of major...

  • Angiotensin II protects cortical neurons against oxygen glucose deprivation-induced injury in vitro. MINGTAN TANG; LI ZHAO; YANQING CHEN; LIXIANG WANG; XIUMEI ZHANG // Biomedical Reports;2014, Vol. 2 Issue 1, p112 

    Ischemic cerebrovascular disease is a common type of cerebrovascular disease and the leading cause of disability and mortality worldwide. Therefore, it is crucial to elucidate its pathogenesis and develop novel therapeutic strategies. This study was performed to investigate whether angiotensin...

  • Citations and Clinicians' Notes: Ischaemic Heart Disease.  // Current Medical Literature: Cardiology;2003, Vol. 22 Issue 3, p66 

    Presents a clinicians notes on ischaemic heart disease. Economic outcomes of multivessel coronary stenting compared with bypass surgery; Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel; Intervention and cardiovascular disease in patients...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics